These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20044275)
1. Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure. Despas F; Guerriero E; Galinier M; Senard J; Pathak A J Heart Lung Transplant; 2010 May; 29(5):591-2. PubMed ID: 20044275 [No Abstract] [Full Text] [Related]
2. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. Kyuma M; Nakata T; Hashimoto A; Nagao K; Sasao H; Takahashi T; Tsuchihashi K; Shimamoto K J Nucl Med; 2004 Feb; 45(2):155-63. PubMed ID: 14960630 [TBL] [Abstract][Full Text] [Related]
3. Cardiac sympathetic nerve activity can detect congestive heart failure sensitively in patients with hypertrophic cardiomyopathy. Hiasa G; Hamada M; Saeki H; Ogimoto A; Ohtsuka T; Hara Y; Shigematsu Y Chest; 2004 Sep; 126(3):679-86. PubMed ID: 15364742 [TBL] [Abstract][Full Text] [Related]
4. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J; J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504 [TBL] [Abstract][Full Text] [Related]
5. The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure. Wolinsky D; Hendel R; Cerqueira M; Gold M; Narula J; Singh J; Shaw L; Thomas G; Wazni O; Farnum C Am J Cardiol; 2015 Oct; 116 Suppl 1():S1-9. PubMed ID: 26454812 [TBL] [Abstract][Full Text] [Related]
6. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. Arimoto T; Takeishi Y; Niizeki T; Nozaki N; Hirono O; Watanabe T; Nitobe J; Tsunoda Y; Suzuki S; Koyama Y; Kitahara T; Okada A; Takahashi K; Kubota I J Card Fail; 2007 Feb; 13(1):34-41. PubMed ID: 17339001 [TBL] [Abstract][Full Text] [Related]
7. Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload. Imamura Y; Ando H; Ashihara T; Fukuyama T J Am Coll Cardiol; 1996 Aug; 28(2):371-5. PubMed ID: 8800112 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Imamura Y; Fukuyama T; Mochizuki T; Miyagawa M; Watanabe K; Jpn Circ J; 2001 Mar; 65(3):155-60. PubMed ID: 11266187 [TBL] [Abstract][Full Text] [Related]
11. Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure. Martins da Silva MI; Vidigal Ferreira MJ; Morão Moreira AP Rev Port Cardiol; 2013 Jun; 32(6):509-16. PubMed ID: 23731734 [TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure. Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055 [TBL] [Abstract][Full Text] [Related]
13. Comparison between iodine 123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure. Somsen GA; Szabó BM; van Veldhuisen DJ; de Milliano PA; de Groot CA; Lie KI Am Heart J; 1997 Sep; 134(3):456-8. PubMed ID: 9327702 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of cardiac sympathetic nerve activity in children with chronic heart failure using quantitative iodine-123 metaiodobenzylguanidine imaging]. Karasawa K; Ayusawa M; Noto N; Sumitomo N; Okada T; Harada K J Cardiol; 2000 Dec; 36(6):387-95. PubMed ID: 11190582 [TBL] [Abstract][Full Text] [Related]
15. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients. Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV J Heart Lung Transplant; 2008 Nov; 27(11):1251-6. PubMed ID: 18971099 [TBL] [Abstract][Full Text] [Related]
16. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299 [TBL] [Abstract][Full Text] [Related]